348 related articles for article (PubMed ID: 31731034)
1. Tumor budding in colorectal carcinoma: An institutional interobserver reliability and prognostic study of colorectal adenocarcinoma cases.
Hacking S; Angert M; Jin C; Kline M; Gupta N; Cho M; Thomas R; Lee L; Chavarria H; Nasim M
Ann Diagn Pathol; 2019 Dec; 43():151420. PubMed ID: 31731034
[TBL] [Abstract][Full Text] [Related]
2. Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer.
Dawson H; Galuppini F; Träger P; Berger MD; Studer P; Brügger L; Zlobec I; Inderbitzin D; Lugli A
Hum Pathol; 2019 Mar; 85():145-151. PubMed ID: 30428391
[TBL] [Abstract][Full Text] [Related]
3. Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer.
Karamitopoulou E; Zlobec I; Kölzer V; Kondi-Pafiti A; Patsouris ES; Gennatas K; Lugli A
Mod Pathol; 2013 Feb; 26(2):295-301. PubMed ID: 23018875
[TBL] [Abstract][Full Text] [Related]
4. Novel prognostic histopathological grading system in oral squamous cell carcinoma based on tumour budding and cell nest size shows high interobserver and intraobserver concordance.
Boxberg M; Bollwein C; Jöhrens K; Kuhn PH; Haller B; Steiger K; Wolff KD; Kolk A; Jesinghaus M; Weichert W
J Clin Pathol; 2019 Apr; 72(4):285-294. PubMed ID: 30530818
[TBL] [Abstract][Full Text] [Related]
5. Interobserver variability in the H&E-based assessment of tumor budding in pT3/4 colon cancer: does it affect the prognostic relevance?
Martin B; Schäfer E; Jakubowicz E; Mayr P; Ihringer R; Anthuber M; Schenkirsch G; Schaller T; Märkl B
Virchows Arch; 2018 Aug; 473(2):189-197. PubMed ID: 29626253
[TBL] [Abstract][Full Text] [Related]
6. Validation of the International Tumor Budding Consensus Conference (ITBCC) 2016 recommendation in squamous cell carcinoma of the lung-a single-center analysis of 354 cases.
Neppl C; Zlobec I; Schmid RA; Berezowska S
Mod Pathol; 2020 May; 33(5):802-811. PubMed ID: 31796876
[TBL] [Abstract][Full Text] [Related]
7. Reporting of tumor budding in colorectal adenocarcinomas using ×40 objective: A practical approach for resource constrained set-ups.
Roy P; Datta J; Roy M; Mallick I; Mohandas M
Indian J Cancer; 2017; 54(4):640-645. PubMed ID: 30082550
[TBL] [Abstract][Full Text] [Related]
8. Tumor Budding in Colorectal Carcinoma Showing a Paradoxical Mitotic Index (Via PHH3) With Possible Association to the Tumor Stromal Microenvironment.
Hacking S; Sajjan S; Angert M; Ebare K; Jin C; Chavarria H; Kataria N; Zhang L; Cho M; Thomas R; Lee L; Nasim M
Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):627-634. PubMed ID: 31567276
[TBL] [Abstract][Full Text] [Related]
9. Tumor Budding in Colorectal Carcinoma: Translating a Morphologic Score Into Clinically Meaningful Results.
Cho SJ; Kakar S
Arch Pathol Lab Med; 2018 Aug; 142(8):952-957. PubMed ID: 30040461
[TBL] [Abstract][Full Text] [Related]
10. Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer.
Horcic M; Koelzer VH; Karamitopoulou E; Terracciano L; Puppa G; Zlobec I; Lugli A
Hum Pathol; 2013 May; 44(5):697-705. PubMed ID: 23159156
[TBL] [Abstract][Full Text] [Related]
11. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.
Lugli A; Kirsch R; Ajioka Y; Bosman F; Cathomas G; Dawson H; El Zimaity H; Fléjou JF; Hansen TP; Hartmann A; Kakar S; Langner C; Nagtegaal I; Puppa G; Riddell R; Ristimäki A; Sheahan K; Smyrk T; Sugihara K; Terris B; Ueno H; Vieth M; Zlobec I; Quirke P
Mod Pathol; 2017 Sep; 30(9):1299-1311. PubMed ID: 28548122
[TBL] [Abstract][Full Text] [Related]
12. Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer.
Wang LM; Kevans D; Mulcahy H; O'Sullivan J; Fennelly D; Hyland J; O'Donoghue D; Sheahan K
Am J Surg Pathol; 2009 Jan; 33(1):134-41. PubMed ID: 18971777
[TBL] [Abstract][Full Text] [Related]
13. Should a fourth category be added to the international tumor budding consensus conference tumor budding scoring system in colorectal adenocarcinomas?
Secinti IE; Ozgur T; Gursoy D; Dede I
APMIS; 2022 Sep; 130(9):560-567. PubMed ID: 35816469
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of tumor budding in gallbladder cancer: application of the International Tumor Budding Consensus Conference scoring system.
Kim HN; Lee SY; Kim BH; Kim CY; Kim A; Kim H
Virchows Arch; 2021 Jun; 478(6):1071-1078. PubMed ID: 33398430
[TBL] [Abstract][Full Text] [Related]
15. Digital image analysis of pan-cytokeratin stained tumor slides for evaluation of tumor budding in pT1/pT2 colorectal cancer: Results of a feasibility study.
Jepsen RK; Klarskov LL; Lippert MF; Novotny GW; Hansen TP; Christensen IJ; Høgdall E; Riis LB
Pathol Res Pract; 2018 Sep; 214(9):1273-1281. PubMed ID: 30017334
[TBL] [Abstract][Full Text] [Related]
16. Interobserver agreement of a gastric adenocarcinoma tumor regression grading system that incorporates assessment of lymph nodes.
Tsekrekos A; Vieth M; Ndegwa N; Bateman A; Flejou JF; Grabsch HI; Mastracci L; Meijer SL; Saragoni L; Sheahan K; Shetye J; Yantiss R; Lundell L; Detlefsen S
Hum Pathol; 2021 Oct; 116():94-101. PubMed ID: 34284051
[TBL] [Abstract][Full Text] [Related]
17. Tumor Budding in Colorectal Carcinoma: Confirmation of Prognostic Significance and Histologic Cutoff in a Population-based Cohort.
Graham RP; Vierkant RA; Tillmans LS; Wang AH; Laird PW; Weisenberger DJ; Lynch CF; French AJ; Slager SL; Raissian Y; Garcia JJ; Kerr SE; Lee HE; Thibodeau SN; Cerhan JR; Limburg PJ; Smyrk TC
Am J Surg Pathol; 2015 Oct; 39(10):1340-6. PubMed ID: 26200097
[TBL] [Abstract][Full Text] [Related]
18. Refining the ITBCC tumor budding scoring system with a "zero-budding" category in colorectal cancer.
Zlobec I; Bächli M; Galuppini F; Berger MD; Dawson HE; Nagtegaal ID; Lugli A
Virchows Arch; 2021 Dec; 479(6):1085-1090. PubMed ID: 33843013
[TBL] [Abstract][Full Text] [Related]
19. Validation of the International Tumor Budding Consensus Conference (2016) recommendations in oral tongue squamous cell carcinoma.
Xie N; Yu P; Liu H; Liu X; Hou J; Chen X; Huang H; Wang C
J Oral Pathol Med; 2019 Jul; 48(6):451-458. PubMed ID: 30927486
[TBL] [Abstract][Full Text] [Related]
20. Budding, tumor-infiltrating lymphocytes, gland formation: scoring leads to new prognostic groups in World Health Organization low-grade colorectal cancer with impact on survival.
Lang-Schwarz C; Melcher B; Haumaier F; Schneider-Fuchs A; Lang-Schwarz K; Krugmann J; Vieth M; Sterlacci W
Hum Pathol; 2019 Jul; 89():81-89. PubMed ID: 31054898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
